At 3.5% CAGR, the Middle East & Africa Diagnostic Imaging Market is projected to be worth US$ 1,639.49 million by 2028, says Business Market Insights   

According to Business Market Insights’ research, the Middle East & Africa diagnostic imaging market was valued at US$ 1,334.22 million in 2021 and is expected to reach US$ 1,639.49 million by 2028, registering an annual growth rate of 3.5% from 2021 to 2028. widening government initiatives for diagnostic imaging services reach globally and sanctioning funds and grants and increased use of artificial intelligence (AI) and analytics in diagnostic imaging equipment.                

Artificial intelligence helps improve numerous aspects of the healthcare industry, and diagnostic imaging technique is one of the fields that would benefit greatly. Diagnostic imaging equipment manufacturers worldwide are integrating AI into their products. For example, in September 2018, Nvidia announced launching the Nvidia Clara platform, a combination of software and hardware working together in diagnostic imaging equipment. Such ground-breaking technology can address the challenges of medical instruments and process enormous amounts of data generated every second that doctors and scientists can easily interpret. Additionally, in August 2018, Google's DeepMind announced launching an AI system that can quickly detect over 50 eye disorders using routine medical scans. DeepMind's AI assistant for diagnostic imaging can automatically tackle eye-related issues by identifying disease symptoms within seconds and prioritizing patients who seek urgent care. AI supportive diagnostic imaging equipment play a vital role in diagnosing and classifying cancers. AI plays a pivotal role in the automated recognition of features from sample medical images while performing diagnostic imaging tasks. For example, automated AI applications enhanced clinicians' qualitative potentials, including detection of numerous tumor lesions at a time among patients, prediction of the resultant tumor by referring to the various databases within a short period, translation of phenotypic variations to genotypic, and persistent monitoring of patients. Further, AI generalizes disease imaging techniques with minimal errors resulting in an earlier and more significant diagnosis of diseases.  

On the contrary, shortage of skilled healthcare professionals and high costs related to diagnostic imaging equipment. 

Based on modality, the Middle East & Africa diagnostic imaging market is segmented into X-ray, computed tomography, endoscopy, ultrasound, magnetic resonance imaging (MRI), nuclear imaging, mammography, and others. The computed tomography segment held 21.6% market share in 2021, amassing US$ 288.00 million. It is projected to garner US$ 384.65 million by 2028 to expand at 4.9% CAGR during 2021–2028.

Based on application, the Middle East & Africa diagnostic imaging market is segmented into cardiology, oncology, neurology, orthopedics, gastroenterology, obstetrics/gynecology, and others. The cardiology segment held 29.4% market share in 2021, amassing US$ 391.91 million. It is projected to garner US$ 495.45 million by 2028 to expand at 4.0% CAGR during 2021–2028.

Based on end user, the Middle East & Africa diagnostic imaging market is categorized into hospitals and clinics, diagnostic imaging centers, ambulatory surgical centers (ASCs), and others. The hospitals and clinics segment held 42.0% market share in 2021, amassing US$ 561.002 million. It is projected to garner US$ 696.239 million by 2028 to expand at 3.7% CAGR during 2021–2028.

Based on country, the Middle East & Africa diagnostic imaging market has been segmented into Saudi Arabia, South Africa, the UAE, and Rest of MEA.  Our regional analysis states that Saudi Arabia captured 35.9% market share in 2021. It was assessed at US$ 479.08 million in 2021 and is likely to hit US$ 609.22 million by 2028, exhibiting a CAGR of 4.1% during the forecast period.  

Key players dominating the Middle East & Africa diagnostic imaging market are General Electric Company; Siemens Healthineers; Koninklijke Philips N.V.; KARL STORZ SE & Co. KG; FUJIFILM Holdings Corporation; Canon Inc.; Hologic, Inc.; Carestream Health Inc.; Stryker Corporation; and Olympus Corporation among others.

• In March 2022, Fujifilm India Pvt Ltd unveiled a new range of products at the 74th National Annual Conference of IRIA 2022. The latest portfolio includes a plethora of products offering complete and integrated solutions for diagnostic purposes, including CT, MRI, X-ray, AI, PACS, endoscopy, and ultrasound systems.  

• In April 2021, RadNet, Inc. and Hologic, Inc. entered into a definitive collaboration to advance the use of artificial intelligence (A.I.) in breast health. The collaboration enabled new market opportunities and efforts to build clinician's trust and develop and integrate new A.I. technologies.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com